Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 7Neoplasms 6Colonic Neoplasms 3Urinary Bladder Neoplasms 2Respiratory Aspiration 2Prostatic Neoplasms 2Uterine Neoplasms 1Thyroid Neoplasms 1Rectal Neoplasms 1Quality of Recovery 1Postoperative Complications 1Postoperative Cognitive Complications 1Pituitary Neoplasms 1Neurofibromatoses 1Myofibroma 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Inflammation 1Hypoxia 1Hydrocephalus 1Headache 1Female Breast Carcinoma 1Epilepsy 1Endoplasmic Reticulum Stress 1Delirium 1Cough 1Abdominal Neoplasms 1

Interventions

LY3295668 erbumine 2Everolimus 2ziprasidone 1enzalutamide 1clevidipine 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sirolimus 1Sevoflurane 1Sevelamer 1Saline Solution 1Rocuronium 1Propofol 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nitrous Oxide 1Nifedipine 1Nafcillin 1Molindone 1Midazolam 1Methylprednisolone 1Mass Screening 1Lurasidone Hydrochloride 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Epilepsy × Sevoflurane × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡